Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Shire Pharmaceuticals
Shire Pharmaceuticals
Activities:
Research & Development
Pharmaceutical
X
LinkedIn
Trending Articles
Neopac showcases latest tube, dispensing and cap innovations at Pharmapack Paris
Highlights include company’s reduced material LowPro caps and world’s smallest child resistant tube
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Indian government bans three medicines owing to health risks
Decision follows strong stand on suspending marketing of all drugs prohibited for sale in other countries, including the US, UK, EU and Australia
You need to be a subscriber to read this article.
Click here
to find out more.
Parenteral preparations: formulation challenges
Parenteral preparations are defined as solutions, suspensions, emulsions for injection or infusion, powders for injection or infusion, gels for injection and implants. They are...
Lonza’s capsule delivers acid-sensitive ingredients to the intestine
The capsule can simplify the manufacturing process to accelerate drug development and expedite first-in-human timelines
Upcoming event
BioProcess International Europe
9-12 April 2024 | Exhibition | RAI Amsterdam
See all
Related Content
Manufacturing
Rentschler Biopharma completes acquisition of US manufacturing site
Company’s first foothold in the US grants access to new technologies, innovation and talent
Manufacturing
Rentschler Biopharma to purchase US manufacturing site from Shire
Under the terms of the agreement, Rentschler Biopharma will continue to manufacture product for Shire at the site
Regulatory
Drug application for Intuniv to treat adult ADHD
Shionogi has filed an application in Japan to expand the application to include adults with the disease
Media
Takeda shows significant profit dip in Q1
Takeda will be looking to Shire’s drug pipeline to bolster future sales after disappointing Q1 results, says GlobalData
Media
GlobalData publishes analysis of top 25 global pharma companies
The data and analytics company has tracked the market cap performance of the top 25 pharma companies for the quarter ending 31 March, 2018 compared to 2017 revealing a number of interesting insights
Finance
Shire announces sale of oncology business to Servier for $2.4 billion
Oncology business provides Servier with an immediate presence in the US, enhancing its commitment to addressing unmet patient needs in oncology
Media
Shire announces collaboration with National Institute of Bioprocessing
A global biotechnology company looking at rare diseases, announced a professional training and development collaboration with the National Institute of Bioprocessing Research and Training in Dublin
Subscribe now